Last Updated on January 6, 2024 by The Health Master
NEW DELHI: In a move to curb profiteering on medicines, the government is set to fix trade margins of drugs usually used by patients for a long period, such as anti-infectives and those used to treat cancer and chronic kidney diseases, top sources said.
Health minister Mansukh Mandaviya has called for a meeting with pharma industry representatives on July 26 to discuss the final proposal.
According to the proposal, the government plans to cap the margins earned by wholesalers, distributors, and retailers in a phased manner.
The proposal has been finalized by the Department of Pharmaceuticals and drug price regulator National Pharmaceutical Pricing Authority (NPPA).
The move assumes significance not only because it is expected to bring down prices of medicines, but the reduction will also reflect in household healthcare expenditure as the government is targeting medicines in specific therapeutic categories and classes of drugs that are priced high and mostly taken by patients on a regular basis or for a very long time.
Trade margin is the difference between the price at which a manufacturer sells the product to a distributor or stockist and the price paid by the end consumer (MRP).
While prices of over 355 medicine formulations that are part of the National List of Essential Medicines are capped directly by the government, the idea behind trade margin rationalization is to bring under the scanner other drugs that are not part of NLEM but are commonly used and are expensive, contributing substantially to health expenditure.
In February 2019, the NPPA capped trade margins of 41 anti-cancer medicines at up to 30% on a pilot basis. It also fixed the prices of coronary stents and knee implants.
During Covid-19, the government capped trade margins of several commonly used medical devices such as pulse oximeters, glucometers, oxygen concentrators, and digital thermometers.
Read more on the National List of Essential Medicines, click the below link
National List of Essential Medicines
Govt launches three schemes for Pharma Industry
USFDA gives nod for this Blood Pressure injection
NMC directs State Medical Councils to take action against Quacks
FDA Haryana team raided, Codeine syrup recovered, FIR lodged
Dostarlimab: A wonder new drug ? shown positive results in a Clinical Trial
Section 37 NDPS Act: Supreme Court Rules this reagrding granting bail
CDSCO panel gives nod to study Dupilumab with these conditions
Govt to roll out schemes for strengthening Pharma Industry
Pharma Industry seeks clarity over these mandatory digital labeling
Latest Notifications regarding Pharmaceuticals
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
